Leidos Invests $10M in AI Disease Detection with University of Pittsburgh

Leidos is committing $10 million to advance artificial intelligence in disease detection and management, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE), announced in a press release. This five-year partnership aims to develop AI-powered tools for quicker detection of diseases such as heart disease and cancer, thereby reducing diagnostic turnaround times and enabling earlier, more effective care management.

The collaboration will focus on establishing a world-class research hub at the University of Pittsburgh, enhancing its Digital Pathology Research Center. This initiative will drive pioneering research in digital pathology and AI-driven diagnostics. Additionally, the partnership aims to develop digital health care solutions, cementing the University of Pittsburgh's leadership in digital pathology and enabling Leidos to create innovative solutions for digital health and diagnostics.

Leidos plans to leverage this collaboration to deploy AI-powered digital pathology solutions across public and private health care sectors, with the goal of leading the commercialization of innovative health care technologies. The initiative will also focus on workforce development and education, cultivating the next generation of health care and AI innovators through comprehensive educational programs and hands-on internship opportunities.